Eucommia ulmoides (EU) (also known as “Du Zhong” in Chinese language) is a plant containing various kinds of chemical constituents such as lignans, iridoids, phenolics, steroids, flavonoids, and other compounds. These constituents of EU possess various medicinal properties and have been used in Chinese Traditional Medicine (TCM) as a folk drink and functional food for several thousand years. EU has several pharmacological properties such as antioxidant, anti-inflammatory, antiallergic, antimicrobial, anticancer, antiaging, cardioprotective, and neuroprotective properties. Hence, it has been widely used solely or in combination with other compounds to treat cardiovascular and cerebrovascular diseases, sexual dysfunction, cancer, metabolic syndrome, and neurological diseases. This review paper summarizes the various active ingredients contained in EU and their health-promoting properties, thus serving as a reference material for the application of EU.
1. Introduction
Eucommia ulmoides (EU) (commonly called “Du Zhong” in Chinese language) belong to the family of Eucommiaceae, a genus of the small tree native to Central China [1]. This plant is widely cultivated in China on a large scale because of its medicinal importance. About 112 compounds have been isolated from EU which include lignans, iridoids, phenolics, steroids, and other compounds. Complementary herbs formula of this plant (such as delicious tea) has shown some medicinal properties. The leaf of EU has higher activity related to cortex, flower, and fruit [2, 3]. The leaves of EU have been reported to enhance bones strength and body muscles [4], thus leading to longevity and promoting fertility in humans [5]. Delicious tea formula made from the leaf of EU was reported to reduce fattiness and enhance energy metabolism. Flavonoid compounds (such as rutin, chlorogenic acid, ferulic acid, and caffeic acid) have been reported to exhibit antioxidants activity in the leaves of EU [6].
Although there has been enough literature on phytochemical properties of EU, few studies however existed on the pharmacological properties of the various compounds extracted from the barks, seeds, stems, and leaves of EU. This review paper will elucidate detailed information regarding different compounds extracted from the various parts (barks, seeds, stem, and leaf) of EU and the prospective uses of these compounds in health-promoting properties with scientific lines of evidence and thus provide a reference material for the application of EU.
2. Chemical Composition of Eucommia ulmoides
Various compounds isolated from different parts of EU are shown in Table 1.
Compounds isolated from various parts of Eucommia ulmoides.
Lignans and their derivatives are the key components of EU [7]. To date, 28 lignans (such as bisepoxylignans, monoepoxylignans, neolignans, and sesquilignans) have been isolated from bark, leaves, and seeds of EU. Iridoid glycoside, a class of secondary metabolites, is the second main component of EU. Iridoids are typically found in plants known as glycosides. Twenty-four iridoids have been isolated and identified from EU (Table 1). These isolated compounds include geniposidic acid, aucubin, and asperuloside which have been reported to have wide pharmacological properties [8–10]. Two new compounds of iridoids, Eucommides-A and -C, have recently been isolated. These two natural compounds are considered as conjugates of iridoid and amino acids. However, the mechanism underlying their activity is not available [11].
2.2. Phenolic Compounds
Phenolic compounds which are derived from the foods have been reported to have positive impact on human health [12, 13]. About 29 phenolic compounds have been isolated and identified from EU [14]. Total content of phenolic compounds (in gallic acid equivalents of all the extracts) was analyzed using the Folin-Ciocalteu phenol reagent. Effects of seasonal variation on the contents of some compounds and antioxidants have been reported. Within the same year, higher contents of phenolics and flavonoids were discovered in the leaves of EU in August and May, respectively. Rutin, quercetin, geniposidic acid, and aucubin existed in higher concentration in May or June [15]. Moreover, higher activity of 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging activity and metal ion chelating ability were found in the leaves of EU harvested in August. Increased content of food antioxidants was also reported in May when compared to other periods of the year [15]. The leaf of EU has been found to be a rich source of aminoacids, vitamins, minerals, and flavonoids such as quercetin, rutin, and geniposidic acid [11, 16]. A total of 7 flavonoids have been isolated from Eucommia plants [17]. Rutin and quercetin are the most important flavonoids [18]. Flavonoids are important compounds which are common in nature and are considered as secondary metabolites and function as chemical messengers, physiological regulators, and cell cycle inhibitors.
2.3. Steroids and Terpenoids
Six steroids and five terpenoids have been extracted and categorized from EU. These include β-sitosterol, daucosterol, ulmoprenol, betalin, betulic acid, ursolic acid, eucommidiol, rehmaglutin C, and 1,4α,5,7α-tetrahydro-7-hydroxymethyl-cyclopenta[c]pyran-4-carboxylic methyl ester which was specifically isolated from the bark of EU [19]. Loliolide has also been isolated from the leaves [20].
2.4. Polysaccharides
Polysaccharides from EU for 15 days at the concentrations of 300–600 mg/kg were reported to exhibit protective effects on kidneys as observed by malonaldehyde and glutathione levels after renal perfusions [21]. Histological examination also showed evidence of antioxidative properties. Extracts from the bark of EU using 70% ethanol also showed protective effects against cadmium at 125–500 mg/kg [22]. Histological examination also showed that EU in combination with Panax pseudoginseng at 25% and 50% weight, respectively, for six weeks at a dose rate of 35.7–41.6 mg/kg exerted light protective effects on glomerular filtration rate [8]. Two new polysaccharides have been separated from EU, which are eucomman A and B [23].
2.5. Other Ingredients and Chemicals
Amino acids, microelements, vitamins, and fatty acids have also been isolated from EU [17, 21–23]. Sun et al. also discovered new compounds such as n-octacosanoic acid, and tetracosanoic-2,3-dihydroxypropylester from EU [24].
Fatty acid composition of oil extracted from the seed of EU showed different concentrations of polyunsaturated fatty acids such as linoleic acid, linolenic acid (56.51% of total fatty acids, TFAs), and linolelaidic acid (12.66% of TFAs). Meanwhile, the main monounsaturated fatty acid isolated from the seed was found to be isoleic acid (15.80% of TFAs). Dominant saturated fatty acids isolated include palmitic acid and stearic acid which represent 9.82% and 2.59% of TFAs, respectively [25].
3. Health-Promoting Compounds of Eucommia ulmoides3.1. Protective Effects on Cardiovascular System
In Chinese traditional medicines, Eucommia is considered as a major herbal tonic for cardiac patients. Eucommia bark extract is an active component used for antihypertensive formulations. It has been confirmed in many human as well as animal models as a vasorelaxant. Lignan from EU when administered to rats of the Okamoto strain (SHR) at the dose rate of 300 mg/kg for 16 weeks resulted in improved vascular remodeling and reduced mean arterial blood pressure. EU minimizes blood pressure at the dose of 500–1000 mg/kg. However, in high fructose fed diet, it develops insulin resistance and hypertension [26–28]. Supplementation of 500 and 1000 mg of EU for 8 weeks and thrice daily for 2 weeks showed minimal reduction in blood pressure and reduction in systolic and diastolic blood pressure [29]. Antihypertensive effect on the parasympathetic nervous system has been reported following the application of EU [30]. EU also serves as a vasorelaxative agent depending on nitric oxide and assumed to be linked with potassium channels [31]. EU has beta blocking potential which at 0.5% w/v reduces isoproterenol-stimulated lipolysis from 2.67 to 1.4 times the buffer control [29]. EU has been demonstrated to prevent hypertensive remodeling which is associated with aldose reductase inhibition [32]. The application of lignans from EU under condition of hypertension due to vascular remodeling was reported to serve as a new therapeutic agent [33].
EU also showed antihyperlipidemic properties by suppressing hepatic fatty acid and cholesterol biosynthesis [34]. In hyperlipidemic hamsters, dietary supplementation with leaf extract of EU at the dose of 0.175 g/100 g for 10 weeks reduced the concentrations of triglycerides, total cholesterol, low-density lipoprotein cholesterol (LDL-C), non-high-density lipoprotein cholesterol (non-HDL-C), and free acids in plasma and hepatic lipids compared to control group (fed 10 g, coconut oil, 0.2% cholesterol, w/w) [34]. In a similar manner, 1 mg or 5 mg intraduodenal injection of EU leaf extract reduced plasma triglyceride levels [65].
3.2. Antioxidant Effects
Antioxidant compounds from Eucommia plant reduced the level of free radicals [66, 67] and improved the disease condition caused by oxidative stress [68, 69]. Strong antioxidant properties of EU have been established under in vivo and in vitro studies [70, 71]. Extracts from EU reduced the level of hydrogen peroxide which expresses some caspase proteins by MC3T3E1 cells up to half concentration from 12.5 to 25 μg/mL [71]. Extract of EU was reported to increase the actions of erythrocyte, superoxide dismutase, and catalase and glutathione peroxidase and reduce the concentration of hydrogen peroxide and lipid peroxide in erythrocytes, liver, and kidney [70]. Studies on diabetic rats indicated that superoxide dismutase (SOD) can be enhanced by Eucommia bark. Eucommia also increases the level of other antioxidant enzymes in the blood to neutralize free radicals [70].
Phenolics and flavonoids of medicinal herbs contributed significantly to oxidative activities in EU [34, 69–72]. Phenolics and flavonoids safely react with free radicals by donating a hydrogen atom or an electron and terminate chain reaction before the vital organs are damaged [73]. Antioxidant properties from leaves of the EU roasted cortex and seeds were analyzed by calculating radical scavenging activity of 2,2-diphenyl-1-picrylhydrazyl and ferric reducing antioxidant power and lipid peroxidation inhibition capacity in a β-carotene/linoleic acid system. Results indicated that leaf of the extract showed maximum DPPH radical scavenging activity with reducing rate and inhibition rate of 81.40%, followed by butylated hydroxytoluene (BHT) (76.60%) and the roasted cortex extract (16.72%). However, the seed extract had the lowest activity of 7.65%. In ferric reducing antioxidant power assays, the order of ferric reducing activities of EU extracts from leaf, seed, and roasted cortex was compared with positive control. In the β-carotene/linoleic acid emulsion system, the leaf extract showed better antioxidant capacity (43.58%) than the roasted cortex extract (26.71%) or seed extract (25.10%) [74].
In addition, aucubin compounds of EU have been demonstrated to exhibit photoprotective effects against oxidative stress. Ultraviolet (UV) B radiation produces free radicals in the skin which induce the synthesis of metalloproteinases (MMPs) causing photoaging in the skin, wrinkling, and discoloration which are prone to cancer. Aucubin played a vital role in defense mechanism against free radicals caused by UV irradiation [75].
3.3. Antibacterial, Antiviral, and Anti-Inflammatory Activity
EU have been reported to inhibit the growth of bacteria and reduce the secretion of proinflammatory cytokines in few studies. Ethanol extracts of EU at the dose rate of 0.1 and 1.0 mg/mL of 95% (v/v) were reported to exhibit some antibacterial (against Acinetobacter baumannii and Staphylococcus aureus) and antifungal (against Aspergillus fumigatus) effects [15–34, 65–76]. Furthermore, it has been reported that the same concentration of 0.1 mg/mL EU extracts reduces the secretion of proinflammatory cytokines including tumor necrosis factor-alpha (TNF-α), interleukin-8 (IL-8), and IL-1β by human monocytic (THP-1) cells pretreated with heat-killed P. acnes. Aqueous extract of EU significantly decreased cyclooxygenase-2 (COX-2) enzyme with IC50 = 9.92 mg/mL, although the effects were lowered compared with nonsteroid anti-inflammatory drugs [54]. Cortex of EU at the concentration of 0.1 and 0.5 mg/mL decreased production of (TNF-α, IL-6, and COX-2) prostaglandin E and nitric oxide [77].
Suppression of HIV infection has also been reported with daily intake of EU extracts or its alkaline extracts in tea formula. Alkaline extract of EU leaf in combination with 22% uronic acid, 27% reducing sugars, and 46% neutral sugars reduced HIV-induced cytopathicity (HTLV-III) with extremely low cytotoxicity in infected MT-4 cells (EC50) [78]. Lv et al. also demonstrated that the samples from EU Oliver had potent inhibitory activity against the HIV gp41 six-helix bundle formation [79].
3.4. Antiobesity Effects
Previous studies have shown that EU has antiobesity and antimetabolic syndrome properties [8, 26, 34, 80, 81]. It has been demonstrated that both Eucommia leaf extract (ELE) and Eucommia green leaf powder (EGLP) markedly suppressed body weight and white adipose tissue (WAT) in female ICR mice fed high-fat diets (HFD). The antiobesity effect of Eucommia green leaf extract (EGLE) has been linked to various compounds such as geniposidic acid, asperuloside, and chlorogenic acid which was isolated from the extract [8]. Application of water extract from the leaf of EU at the rate of 5% diet was reported to reduce fat accumulation rate in osteoporotic mice [4] although application of 500–1000 mg/kg EU leaf extract beyond 4 weeks showed no effect on fat accumulation in fructose overfed rats [26].
Antiobesity and antimetabolic syndrome activity in rat fed with a 35% high-fat diet could be maintained through secretion and regulation of adipocytokines that depend on the accumulation of visceral fat to improve insulin resistance or hyperlipidemia [80]. Administration of EU extracts at the concentration of 300–1600 mg/kg intake has been reported to enhance gene expressions for fat oxidation [81]. Administration of the extract was confirmed to increase fat oxidation in liver [34, 54, 65–81]. This increased fat oxidation in liver following administration of EU extract was attributed to the rate limiting stages of β-oxidation (CPT1A, ACOX1, and ACADVL), α-oxidation, and ω-oxidation (CYP4A1) [81].
3.5. Neuroprotective Effects
The stem bark extract of EU exhibited acetylcholinesterase inhibition properties in vitro (172 μg/mL) IC50 and neuroprotective effects against beta-amyloid proteins [4]. It also inhibits 30–70% of cytotoxicity and efficacy of oxidative biomarkers when applied at a concentration of 2.5 μg/mL [10]. Stem bark extract of EU showed higher protection activity against memory dysfunctions at the dose of 10–20 mg/kg with intracerebral injection of beta-amyloid proteins in rats [4].
3.6. Metabolic Modulation and Bones
Eucommia cortex extract can be used in the control of osteoporosis. This is because Eucommia extract is actively involved in mechanisms which initiate osteoblast, enhance osteogenesis, decrease osteoclast, and thus prevent osteolysis [82]. Total glycosides from Eucommia ulmoides seed (TGEUS) have been shown to improve bone density and femur strength in rats [83]. Daily administration of TGEUS at the rate of 400 mg/kg body weight/day to normal and Dawley rats was reported to significantly increase bone mineral density and showed improvements in microarchitecture structure of the femur bone [83].
Eucommia cortex extract was reported to induce the release of growth hormone (GH) responsible for bone maturation and bone remodeling. Products of alcoholic extraction from Eucommia bark were reported to be very potent in the release of growth hormone secretagogue. Increasing signals of estrogen receptor alpha has been shown to increase the growth of bone [84]. An exception to this effect was noticed in ovariectomized rats which showed no effect on the growth of bone [47, 82]. In menopausal research model, 5% diet of the EU was observed to minimize the bone loss in ovariectomized rats [61]. Eucommia cortex fed at the dosage of 300–500 mg/kg showed reduced bone mass which is not significantly different from group fed with estradiol drug [61]. Antioxidant properties of Eucommia leaf extract were also reported to contribute positively to the promotion of bone growth by improving cell integrity during oxidative stress when applied at a reduced dosage (6.25 μg/mL) [71]. Therefore, Eucommia extract can be established as a therapeutic agent under conditions of osteoporosis [85].
3.7. Phytoestrogenic Properties
EU was reported to exhibit phytoestrogenic and androgenic properties [84]. Eucommia bark contains isoflavonoids, with estrogen like properties, which bind to human estrogen receptors. None of these isoflavonoids has male hormone like effect that interacts with human androgen receptor. Eucommia bark has been reported to show bimodal phytoandrogenic and hormone enhancing effects [84]. Androgen receptors play a key role in male as well as in female physiology such as skeletal muscle development, bone density, and sex drive [86, 87]. Ethanol extracts of Eucommia bark were reported to attach in a weak manner to activated androgen receptors with high affinity and produce testosterone at the rate of 5–25 ng/mL in mammalian COS-7 cells [84]. Oral induction of the ethanol extract showed no increase in prostatic weights at the dose of 1–50 mg. However, 20% increases in prostatic weights were observed by increasing the dosage up to 5000 μg injection [84]. Application of EU at a concentration of 50 ng/mL enhanced the signals of estradiol in a manner similar to androgen receptors [84]. However, the promoting effect of EU on the cortisol and progesterone receptors was not observed [84].
In vivo animal studies conducted using oral administration of EU extracts potentiated androgenic and hormonal effects. A form of tripartite synergism between sex steroid receptors, sex hormones, and lipidic augmenters isolated from EU was found by Ong and Tan [84]. It has been shown that the activities of sex hormone in the body are optimized with the application of EU [84].
3.8. Hepatoprotective Effects
Study was conducted on different doses of Eucommia ulmoides and carbon tetrachloride on Sprague Dawley male rats to investigate the protective effects of EU in response to CCl4 induced acute liver lipid accumulation. Results demonstrated that Eucommia ulmoides Oliv. cortex extracts (EUCE) significantly decreased the hepatic lipid accumulation induced by CCl4. EU enhances lysosomal enzyme activity relieving protein folding requirement which turns into attenuation of ER stress. ApoB secretion was improved by effects of ER stress; along this, it regulates biotransformation of CCl4 and its resultant inhibition of ROS accumulation [88].
4. Future Perspective and Conclusion
This review paper discusses health-promoting properties of EU on cardiovascular system and antioxidant, antibacterial, antiviral, anti-inflammatory, antiobesity, and neuroprotective effects and metabolic modulation on bones and phytoestrogenic properties. These health-promoting properties have attracted much interest in the extraction and functional development of active ingredients of EU. In further studies, molecular mechanisms underlying certain health-promoting properties of EU need to be explored.
Conflict of Interests
The authors declare that there is no conflict of interests.
Acknowledgments
This work was supported by the National Natural Science Foundation of China (nos. 31330075, 31560640, 31372326, and 31301989), the Science and Technology Department of Hunan province (2015JC3126), and the State Key Laboratory of Animal Nutrition (2004DA125184F1401). The authors are also thankful to CAS-TWAS President’s Fellowship and UCAS financial and infrastructure support.
CallV. B.DilcherD. L.The fossil record of Eucommia (Eucommiaceae) in North America199784679881410.2307/24458162-s2.0-0030743861YenG.-C.HsiehC.-L.Antioxidant activity of extracts from Du-zhong (Eucommia ulmoides) toward various lipid peroxidation models in vitro199846103952395710.1021/jf98004582-s2.0-0001075828ZhangQ.SuY.-Q.YangF.-X.PengJ.-N.LiX.-H.SunR.-C.Antioxidative activity of water extracts from leaf, male flower, raw cortex and fruit of Eucommia ulmoides Oliv2007571274782-s2.0-38349126259KwonS.-H.LeeH.-K.KimJ.-A.HongS.-I.KimS.-Y.JoT.-H.ParkY.-I.LeeC.-K.KimY.-B.LeeS.-Y.JangC.-G.Neuroprotective effects of Eucommia ulmoides Oliv. Bark on amyloid beta25–35-induced learning and memory impairments in mice2011487112312710.1016/j.neulet.2010.10.042NakazawaY.TakedaT.SuzukiN.HayashiT.HaradaY.BambaT.KobayashiA.Histochemical study of trans-polyisoprene accumulation by spectral confocal laser scanning microscopy and a specific dye showing fluorescence solvatochromism in the rubber-producing plant, Eucommia ulmoides Oliver2013238354956010.1007/s00425-013-1912-22-s2.0-84882845627KulomaaA.SirénH.RiekkolaM.-L.Identification of antioxidative compounds in plant beverages by capillary electrophoresis with the marker index technique19977811-252353210.1016/s0021-9673(97)00357-92-s2.0-0030671440HeX.WangJ.LiM.HaoD.YangY.ZhangC.HeR.TaoR.Eucommia ulmoides Oliv.: ethnopharmacology, phytochemistry and pharmacology of an important traditional Chinese medicine20141511789210.1016/j.jep.2013.11.0232-s2.0-84891489182HirataT.KobayashiT.WadaA.UedaT.FujikawaT.MiyashitaH.IkedaT.TsukamotoS.NoharaT.Anti-obesity compounds in green leaves of Eucommia ulmoides20112161786179110.1016/j.bmcl.2011.01.060TundisR.LoizzoM. R.MenichiniF.StattiG. A.MenichiniF.Biological and pharmacological activities of iridoids: recent developments20088439942010.2174/1389557087839559262-s2.0-42949138079ZhouY.LiangM.LiW.LiK.LiP.HuY.YangZ.Protective effects of Eucommia ulmoides Oliv. bark and leaf on amyloid β-induced cytotoxicity200928334234910.1016/j.etap.2009.05.0122-s2.0-70349459249TakamuraC.HirataT.UedaT.OnoM.MiyashitaH.IkedaT.NoharaT.Iridoids from the green leaves of Eucommia ulmoides20077081312131610.1021/np07800462-s2.0-34548612245LinL.-Z.HarnlyJ. M.A screening method for the identification of glycosylated flavonoids and other phenolic compounds using a standard analytical approach for all plant materials20075541084109610.1021/jf062431s2-s2.0-34249855519MattilaP.HellströmJ.Phenolic acids in potatoes, vegetables, and some of their products2007203-415216010.1016/j.jfca.2006.05.0072-s2.0-33846786078ChenX.SangX.LiS.ZhangS.BaiL.Studies on a chlorogenic acid-producing endophytic fungi isolated from Eucommia ulmoides Oliver201037544745410.1007/s10295-010-0690-02-s2.0-77952237380ZhangL.RavipatiA. S.KoyyalamudiS. R.JeongS. C.ReddyN.BartlettJ.SmithP. T.de la CruzM.MonteiroM. C.MelguizoÁ.JiménezE.VicenteF.Anti-fungal and anti-bacterial activities of ethanol extracts of selected traditional Chinese medicinal herbs20136967368110.1016/s1995-7645(13)60117-02-s2.0-84879848452ChenZ.HeJ.TangD.ShiQ.QunxueL.Nutrient distribution and uptake characteristics in Fucommia ulmoides Oliv. plant20041931517ChengJ.ZhaoY. Y.CuiY. X.ChengT. M.Studies on flavonoids from leave of Eucommia ulmoides Oliv2000255284286ChenL.YangZ.Study on dynamic variation of three flavonoids contents in folium eucommiae harvested from different seasons200742930HuaH. M.YinH. Q.LiB. Q.Study on the constituents of the bark of Eucommia ulmoides20031801803OkadaN.ShirataK.NiwanoM.KoshinoH.UramotoM.Immunosuppressive activity of a monoterpene from Eucommia ulmoides199437128128210.1016/0031-9422(94)85042-92-s2.0-0028103529HongY. K.LiuW. J.LiT.SheS.Optimization of extraction of Eucommia ulmoides polysaccharides by response surface methodology20139221761176610.1016/j.carbpol.2012.11.015LiuE.HanL.WangJ.HeW.ShangH.GaoX.WangT.Eucommia ulmoides bark protects against renal injury in cadmium-challenged rats201215330731410.1089/jmf.2011.17562-s2.0-84863244479TomodaM.GondaR.ShimizuN.A reticuloendothelial system-activating glycan from the barks of Eucommia ulmoides199029103091309410.1016/0031-9422(90)80163-bSunY. R.DongJ. X.WuS. G.Studies on chemical constituents from Eucommia ulmoides Oliv200427533352-s2.0-16644364694ZhangL. X.JiX. Y.TanB. B.LiangY. Z.LiangN. N.Identification of the composition of fatty acids in Eucommia ulmoides seed oil by fraction chain length and mass spectrometry2010121381581910.1016/j.foodchem.2009.12.089JinX.AmitaniK.ZamamiY.TakatoriS.HobaraN.KawamuraN.HirataT.WadaA.KitamuraY.KawasakiH.Ameliorative effect of Eucommia ulmoides Oliv. leaves extract (ELE) on insulin resistance and abnormal perivascular innervation in fructose-drinking rats2010128367267810.1016/j.jep.2010.02.0192-s2.0-77951208595LangC.LiuZ.TaylorH. W.BakerD. G.Effect of Eucommia ulmoides on systolic blood pressure in the spontaneous hypertensive rat200533221523010.1142/S0192415X050027952-s2.0-18744403704LuoL.-F.WuW.-H.ZhouY.-J.YanJ.YangG.-P.OuyangD.-S.Antihypertensive effect of Eucommia ulmoides Oliv. extracts in spontaneously hypertensive rats2010129223824310.1016/j.jep.2010.03.0192-s2.0-77952890419GreenwayF.LiuZ.YuY.GuptaA.A clinical trial testing the safety and efficacy of a standardized Eucommia ulmoides oliver bark extract to treat hypertension20111643383472-s2.0-84857407106DeyamaT.NishibeS.NakazawaY.Constituents and pharmacological effects of Eucommia and Siberian ginseng20012212105710702-s2.0-0035206872KwanC. Y.ChenC. X.DeyamaT.NishibeS.Endothelium-dependent vasorelaxant effects of the aqueous extracts of the Eucommia ulmoides Oliv. leaf and bark: implications on their antihypertensive action2004405229235LiZ.-Y.GuJ.YanJ.WangJ.-J.HuangW.-H.TanZ.-R.ZhouG.ChenY.ZhouH.-H.OuyangD.-S.Hypertensive cardiac remodeling effects of lignan extracts from Eucommia ulmoides Oliv. bark—a famous traditional Chinese medicine201341480181510.1142/s0192415x135005472-s2.0-84881153840GuJ.WangJ.-J.YanJ.Effects of lignans extracted from Eucommia ulmoides and aldose reductase inhibitor epalrestat on hypertensive vascular remodeling2011133161310.1016/j.jep.2010.08.055ChoiM.-S.JungU. J.KimH.-J.DoG.-M.JeonS.-M.KimM.-J.LeeM.-K.Du-zhong (Eucommia ulmoides Oliver) leaf extract mediates hypolipidemic action in hamsters fed a high-fat diet2008361819310.1142/s0192415x080056062-s2.0-44049092637DeyamaT.IkawaT.NishibeS.The constituents of Eucommia ulmoides OLIV. II. Isolation and structures of three new lignan glycosides19853393651365710.1248/cpb.33.36512-s2.0-0022380069DeyamaT.IkawaT.KitagawaS.NishibeS.The constituents of Eucommia ulmoides Oliv. III. Isolation and structure of a new lignan glycoside198634252352710.1248/cpb.34.5232-s2.0-0022574270DeyamaT.IkawaT.KitagawaS.NishibeS.The constituents of Eucommia ulmoides Oliv. V. Isolation of dihydroxydehydrodiconiferyl alcohol isomers and phenolic compounds19873551785178910.1248/cpb.35.1785DeyamaT.The constituents of Eucommia ulmoides Oliv. I. Isolation of (+)-medioresinol Di-O-β-D-glucopyranoside19833192993299710.1248/cpb.31.2993SihC. J.RavikumarP. R.HuangF. C.BucknerC.WhitlockH.Jr.Isolation and synthesis of pinoresinol diglucoside, a major antihypertensive principle of Tu-Chung (Eucommia ulmoides, Oliver)197698175412541310.1021/ja00433a070ShiS.-Y.PengM.-J.ZhangY.-P.PengS.Combination of preparative HPLC and HSCCC methods to separate phosphodiesterase inhibitors from Eucommia ulmoides bark guided by ultrafiltration-based ligand screening2013405124213422310.1007/s00216-013-6806-42-s2.0-84886250421WangJ.-X.HaoX.-H.LeiH.-M.YouX.-J.LiJ.-S.Study on the constituents of the bark of Eucommia ulmoides Oliv1996S11315SiC. L.DengX. J.WangD.LiuP. T.LiuZ.Study on chemical compositions of Eucommia ulmoides Oliv. inner bark and its extractives2008285710YaoL. N.Tianjin, ChinaTianjin University2010 (Chinese)GewaliM. B.HattoriM.NambaT.Constituents of the stems of Eucommia ulmoides Oliv198842247248YaoL. N.Studies on the chemical constituents of Eucommia ulmoides oliv2004275341343ChenC. J.ShenS.XiaoT. S.WangQ.JiangJ. Q.LiY.Chemical constituents from the bark of Eucommia ulmoides201282526LiD.WangH. L.ChenJ. M.The chemical constituents of Eucommia ulmoides Oliv.198628528534DeyamaT.IkawaT.KitagawaS.NishibeS.The constituents of Eucommia ulmoides OLIV. IV. isolation of a new sesquilignan glycoside and iridoids19863412493349382-s2.0-0022899635ShimoyamoA.YamadakiM.NakazawaY.Constituents of the leaf of Eucommia ulmoides Oliv19934756DeyamaT.IkawaT.KitagawaS.NishibeS.The constituents of Eucommia ulmoides Oliv. VI. Isolation of a new sesquilignan and neolignan glycosides19873551803180710.1248/cpb.35.1803XuJ. W.LiD.ZhaoP.The constituents of Eucommia ulmoides Oliv198931132GondaR.TomodaM.ShimizuN.KanariM.An acidic polysaccharide having activity on the reticuloendothelial system from the bark of Eucommia ulmoides19903871966196910.1248/cpb.38.19662-s2.0-0025144209SunL. P.MaL.ZhangB.XuH.Research progress of flavonoids in Eucommia ulmoides Oliv200930359363KimB. H.ParkK. S.ChangI.-M.Elucidation of anti-inflammatory potencies of Eucommia ulmoides bark and Plantago asiatica seeds200912476476910.1089/jmf.2008.12392-s2.0-70149088999WeiQ.WangD. M.MaX. H.ZangK. J.A study on the measurement of flavonoids in the leaves of Eucommia ulmoides Oliv200129119123KimH. Y.MoonB. H.LeeH. J.ChoiD. H.Flavonol glycosides from the leaves of Eucommia ulmoides O. with glycation inhibitory activity2004932-322723010.1016/j.jep.2004.03.0472-s2.0-3242716088BiancoA.IavaroneC.TrogoloC.Structure of eucommiol, a new cyclopentenoid-tetrol from Eucommia ulmoides19743023-244117412110.1016/s0040-4020(01)97394-62-s2.0-0000038594NakamuraT.NakazawaY.OnizukaS.SatohS.ChibaA.SekihashiK.MiuraA.YasugahiraN.SasakiY. F.Antimutagenicity of Tochu tea (an aqueous extract of Eucommia ulmoides leaves) 1, the clastogen-suppressing effects of Tochu tea in CHO cells and mice1997388172010.1016/s1383-5718(96)00096-42-s2.0-0031011446BianeoA.BoniniC. C.IavaroneC.TrogoloC.Structure elueidation of eucommioside (2′′-O-β-D- glueopyranosyl eucommiol) from Eucommia ulmoides198221201203HattoriM.CheQ. M.GewaliM. B.Constituents of the leaves of Eucommia ulmoides Oliv.1988427680ZhangW.FujikawaT.MizunoK.IshidaT.OoiK.HirataT.WadaA.Eucommia leaf extract (ELE) prevents OVX-induced osteoporosis and obesity in rats201240473575210.1142/s0192415x125005532-s2.0-84864199380PengY. Z.DengM. R.ZhouF.LiuS.Chemical constituents from leaves of eucommia ulmoides collected from Zhangjiajie201311179181TanakaC.NakamuraT.NakazawaY.NoharaT.A new triterpenoid from the leaves of Eucommia ulmoides OLIV19974581379138010.1248/cpb.45.13792-s2.0-0030774999YaharaS.KatoK.NakazawaY.TodaY.NoharaT.New iridoid trimers and tetramers from seeds of Eucommia ulmoides199038126726910.1248/cpb.38.2672-s2.0-0025233993HoriiY.TanidaM.ShenJ.HirataT.KawamuraN.WadaA.NagaiK.Effects of Eucommia leaf extracts on autonomic nerves, body temperature, lipolysis, food intake, and body weight2010479318118610.1016/j.neulet.2010.05.0302-s2.0-77954145747CaiY.LuoQ.SunM.CorkeH.Antioxidant activity and phenolic compounds of 112 traditional Chinese medicinal plants associated with anticancer200474172157218410.1016/j.lfs.2003.09.0472-s2.0-1142297395DraglandS.SenooH.WakeK.HolteK.BlomhoffR.Several culinary and medicinal herbs are important sources of dietary antioxidants20031335128612902-s2.0-0038708240AkinmoladunA. C.ObuotorE. M.FarombiE. O.Evaluation of antioxidant and free radical scavenging capacities of some Nigerian indigenous medicinal plants201013244445110.1089/jmf.2008.02922-s2.0-77954042153HendraR.AhmadS.OskoueianE.SukariA.ShukorM. Y.Antioxidant, anti-inflammatory and cytotoxicity of Phaleria macrocarpa (Boerl.) Scheff fruit201111, article 11010.1186/1472-6882-11-1102-s2.0-83355174248ParkS. A.ChoiM.-S.JungU. J.KimM.-J.KimD. J.ParkH.-M.ParkY. B.LeeM.-K.Eucommia ulmoides oliver leaf extract increases endogenous antioxidant activity in type 2 diabetic mice20069447447910.1089/jmf.2006.9.4742-s2.0-33846235930LinJ.FanY. J.MehlC.ZhuJ. J.ChenH.JinL. Y.XuJ. H.WangH.-M.Eucommia ulmoides Oliv. Antagonizes H2O2-induced rat osteoblastic MC3T3-E1 apoptosis by inhibiting expressions of caspases 3, 6, 7, and 92011121475410.1631/jzus.B1000057ZhangL.RavipatiA. S.KoyyalamudiS. R.JeongS. C.ReddyN.SmithP. T.BartlettJ.ShanmugamK.MünchG.WuM. J.Antioxidant and anti-inflammatory activities of selected medicinal plants containing phenolic and flavonoid compounds20115923123611236710.1021/jf203146e2-s2.0-83055165707PettiS.ScullyC.Polyphenols, oral health and disease: a review200937641342310.1016/j.jdent.2009.02.0032-s2.0-64549093700XuZ.TangM.LiY.LiuF.LiX.DaiR.Antioxidant properties of du-zhong (Eucommia ulmoides Oliv.) extracts and their effects on color stability and lipid oxidation of raw pork patties201058127289729610.1021/jf100304t2-s2.0-77953624547HoJ. N.LeeY. H.ParkJ. S.JunW. J.KimH. K.HongB. S.ShinD. H.ChoH. Y.Protective effects of aucubin isolated from Eucommia ulmoides against UVB-induced oxidative stress in human skin fibroblasts20052871244124810.1248/bpb.28.12442-s2.0-24944483720TsaiT.-H.TsaiT.-H.WuW.-H.TsengJ. T.-P.TsaiP.-J.In vitro antimicrobial and anti-inflammatory effects of herbs against Propionibacterium acnes2010119396496810.1016/j.foodchem.2009.07.0622-s2.0-70449124421KimM.-C.KimD.-S.KimS.-J.ParkJ.KimH.-L.KimS.-Y.AhnK. S.JangH.-J.LeeS.-G.LeeK.-M.HongS.-H.UmJ.-Y.Eucommiae cortex inhibits TNF-α and IL-6 through the suppression of caspase-1 in lipopolysaccharide-stimulated mouse peritoneal macrophages201240113514910.1142/s0192415x125001152-s2.0-84863038494NakanoM.NakashimaH.ItohY.Anti-human immunodeficiency virus activity of oligosaccharides from rooibos tea (Aspalathus linearis) extracts in vitro199711supplement 3128130LvL.SunY. R.XuW.LiuS. W.RaoJ. J.WuS. G.Isolation and characterization of the anti-HIV active component from Eucommia ulmoides2008316847850FujikawaT.HirataT.WadaA.KawamuraN.YamaguchiY.FujimuraK.UedaT.YurugiY.SoyaH.NishibeS.Chronic administration of Eucommia leaf stimulates metabolic function of rats across several organs2010104121868187710.1017/s00071145100029652-s2.0-78650029943KobayashiY.HiroiT.ArakiM.HirokawaT.MiyazawaM.AokiN.KojimaT.OhsawaT.Facilitative effects of Eucommia ulmoides on fatty acid oxidation in hypertriglyceridaemic rats201292235836510.1002/jsfa.45862-s2.0-83255176898ZhangR.LiuZ. G.LiC.HuS. J.LiuL.WangJ. P.MeiQ. B.Du-Zhong (Eucommia ulmoides Oliv.) cortex extract prevent OVX-induced osteoporosis in rats200945355355910.1016/j.bone.2008.08.1272-s2.0-67949120224LiY.WangM.-J.LiS.ZhangY.-M.ZhaoY.XieR.-M.SunW.-J.Effect of total glycosides from Eucommia ulmoides seed on bone microarchitecture in rats201125121895189710.1002/ptr.35432-s2.0-82155188474OngV. Y. C.TanB. K. H.Novel phytoandrogens and lipidic augmenters from Eucommia ulmoides20077, article 310.1186/1472-6882-7-32-s2.0-33847217991HaH.HoJ.ShinS.KimH.KooS.KimI.-H.KimC.Effects of Eucommiae cortex on osteoblast-like cell proliferation and osteoclast inhibition2003261192993610.1007/bf029802022-s2.0-3042601244DavisonS. L.BellR.Androgen physiology2006242717710.1055/s-2006-9395652-s2.0-33646697526QuigleyC. A.De-BellisA.MarschkeK. B.El-AwadyM. K.WilsonE. M.FrenchF. S.Androgen receptor defects: historical, clinical, and molecular perspectives19951632713212-s2.0-0029069878JinC.-F.LiB.LinS.-M.YadavR.-K.KimH.-R.ChaeH.-J.Mechanism of the inhibitory effects of Eucommia ulmoides Oliv. cortex extracts (EUCE) in the CCl4-induced acute liver lipid accumulation in rats201320131175185410.1155/2013/7518542-s2.0-84884246506